Long Term Effect of AIT in Children
NCT06421415 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-07-10
Summary
The present study will investigate the long term effect of allergen immunotherapy in a real-life study in children with allergy undergoing subcutaneous or sublingual immunotherapy with grass pollen, birch, house dust mites or venom.
Conditions
- Allergy in Children
Interventions
- DRUG
-
Allergen Immunotherapy Extract
Patients will be treated as usual. The study is an observation of the long term effect of the treatment
Sponsors & Collaborators
-
Odense University Hospital
lead OTHER
Principal Investigators
-
Josefine Gradman, PhD · Odense University Hospital
Eligibility
- Min Age
- 4 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-01
- Primary Completion
- 2036-12-01
- Completion
- 2037-05-01
Countries
- Denmark
Study Locations
More Related Trials
-
Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy
NCT01014325 ·Status: UNKNOWN ·Phase: PHASE3
-
Impact of AIT on Allergic Rhinitis and Asthma
NCT04125888 ·Status: COMPLETED
-
House Dust Mite Allergy Trial In Children
NCT04145219 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents
NCT01919554 ·Status: COMPLETED ·Phase: PHASE1
-
Documentation of Efficacy of Intralymphatic Allergen Immunotherapy
NCT05191186 ·Status: COMPLETED ·Phase: PHASE3
-
High and Low Dose Oral Peanut Immunotherapy - Comparison of Efficacy and Safety
NCT04415593 ·Status: COMPLETED ·Phase: NA
-
Effect of Intralymphatic Immunotherapy
NCT02255604 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Nasal Filters on Seasonal Allergic Rhinitis (Hay Fever)
NCT01699165 ·Status: COMPLETED ·Phase: NA
-
Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma
NCT01930461 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Effectiveness and Safety of Sublingual Immunotherapy in Children With Allergic Rhinitis
NCT00698594 ·Status: COMPLETED ·Phase: PHASE4
-
House Dust Mite Injection Immunotherapy in Elderly Patients.
NCT03209245 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Benefits of Sublingual AIT (PRACTIS)
NCT06574061 ·Status: COMPLETED
-
Immunological Comparison of AIT and SCIT Immunotherapy Against Grass Pollen
NCT01889875 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis
NCT03157505 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children
NCT00841256 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis
NCT05400811 ·Status: UNKNOWN ·Phase: PHASE3
-
Treatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or Asthma
NCT04004351 ·Status: COMPLETED
-
N.I.S of AIT in Adult Patients With House Dust Mite Allergy in Real Practice in France
NCT03746860 ·Status: COMPLETED
-
Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts
NCT01608243 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children
NCT03375775 ·Status: COMPLETED ·Phase: NA
-
Mite Asthma Pediatric Immunotherapy Trial
NCT03654976 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Sublingual Immunotherapy on Grasspollen Allergy
NCT00150514 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure chamber-a Randomized Placebo-controlled Double-blind Study
NCT06778213 ·Status: RECRUITING ·Phase: PHASE4
-
Induction of Sustained Unresponsiveness to Peanuts Using High- and Low-dose Peanut Oral Immunotherapy
NCT05163574 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis
NCT04874714 ·Status: TERMINATED ·Phase: PHASE3